Company intelligence / Profile preview

National Enzyme Company

Ownership: Private
Development stage: Commercial

Overview

National Enzyme Company was a pioneer in the development and manufacture of enzyme-based dietary supplements, with a strong focus on digestive health. The company produced proprietary blends of both digestive and systemic enzymes using cGMP methods. Clinical trials conducted by related entities demonstrated positive results for their anti-inflammatory proteolytic enzyme blends in post-operative healing, but NEC itself primarily served as a contract manufacturer rather than a clinical-stage biotech.

Therapeutic areas: GastroenterologyImmunology
Modalities: Protein (Enzymes)Probiotic (in some formulations)Herbal/Whole food concentrate (in some formulations)
Industry: Food & Nutrition

Beyond the preview

Go deeper on National Enzyme Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on National Enzyme Company.

Explore the full profile